{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:22:03Z","timestamp":1791836523035,"version":"4.3.4"},"reference-count":121,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01-DK082874"],"award-info":[{"award-number":["U01-DK082874"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.jhepr.2021.100398","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T11:07:59Z","timestamp":1637320079000},"page":"100398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Humoral immunity in hepatitis B virus infection: Rehabilitating the B in HBV"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0572-8741","authenticated-orcid":false,"given":"Thomas","family":"Vanwolleghem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Adomati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4296-8493","authenticated-orcid":false,"given":"Stijn","family":"Van Hees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry L.A.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2021.100398_bib1","doi-asserted-by":"crossref","first-page":"18035","DOI":"10.1038\/nrdp.2018.35","article-title":"Hepatitis B virus infection","volume":"4","author":"Yuen","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jhepr.2021.100398_bib2","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1136\/gutjnl-2013-305517","article-title":"HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability","volume":"63","author":"Kim","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2021.100398_bib3","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1053\/jhep.2003.50453","article-title":"Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection","volume":"38","author":"Milich","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2021.100398_bib4","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1056\/NEJM200101043440120","article-title":"Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab","volume":"344","author":"Dervite","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhepr.2021.100398_bib5","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1172\/JCI110860","article-title":"Synthesis\u00a0of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers","volume":"71","author":"Dusheiko","year":"1983","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhepr.2021.100398_bib6","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1172\/JCI121957","article-title":"PD-1 blockade partially recovers dysfunctional virus-specific B cells in chronic hepatitis B infection","volume":"128","author":"Salimzadeh","year":"2018","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhepr.2021.100398_bib7","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1172\/JCI121960","article-title":"Circulating and intrahepatic antiviral B cells are defective in hepatitis B","volume":"128","author":"Burton","year":"2018","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhepr.2021.100398_bib8","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jhep.2019.07.015","article-title":"Comparative characterization of B cells specific for HBV nucleocapsid and envelope proteins in patients with chronic hepatitis B","volume":"72","author":"Le Bert","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100398_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2020.01.024","article-title":"Hepatitis B core-specific memory B cell responses associate with clinical parameters in patients with chronic HBV","author":"Vanwolleghem","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100398_bib10","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1053\/j.gastro.2018.10.032","article-title":"Targeting innate and adaptive immune responses to cure chronic HBV infection","volume":"156","author":"Gehring","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2021.100398_bib11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1600-0676.1987.tb00361.x","article-title":"Immunoglobulin on the surface of isolated hepatocytes is associated with antibody-dependent cell-mediated cytotoxicity and liver damage","volume":"7","author":"Vergani","year":"1987","journal-title":"Liver"},{"key":"10.1016\/j.jhepr.2021.100398_bib12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2249.1995.tb03658.x","article-title":"Antibody-directed complement-mediated cytotoxicity to hepatocytes from patients with chronic hepatitis B","volume":"100","author":"Michalak","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jhepr.2021.100398_bib13","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01695-20","article-title":"Characterization of hepatitis B precore\/core-related antigens","volume":"95","author":"Hong","year":"2021","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jhepr.2021.100398_bib14","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/v9030056","article-title":"Complete and incomplete hepatitis B virus particles: formation, function, and application","volume":"9","author":"Hu","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.jhepr.2021.100398_bib15","doi-asserted-by":"crossref","first-page":"8271","DOI":"10.3748\/wjg.v22.i37.8271","article-title":"Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma","volume":"22","author":"Van Hees","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhepr.2021.100398_bib16","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.1128\/JCM.41.12.5598-5603.2003","article-title":"Detection of the hepatitis B virus X protein (HBx) antigen and anti-HBx antibodies in cases of human hepatocellular carcinoma","volume":"41","author":"Hwang","year":"2003","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jhepr.2021.100398_bib17","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/infdis\/164.6.1104","article-title":"Characteristics of hepatitis B X antigen, antibodies to X antigen, and antibodies to the viral polymerase during hepatitis B virus infection","volume":"164","author":"Horiike","year":"1991","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jhepr.2021.100398_bib18","first-page":"289068","article-title":"Anti-hepatitis B virus X protein in sera is one of the markers of development of liver cirrhosis and liver cancer mediated by HBV","volume":"2009","author":"Zhang","year":"2009","journal-title":"J\u00a0Biomed Biotechnol"},{"key":"10.1016\/j.jhepr.2021.100398_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/cells9092023","article-title":"Intracellular trafficking of HBV particles","volume":"9","author":"Jiang","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jhepr.2021.100398_bib20","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1136\/gutjnl-2017-313811","article-title":"Quantification of large and middle proteins of hepatitis B virus surface antigen (HBsAg) as a novel tool for the identification of inactive HBV carriers","volume":"67","author":"Pfefferkorn","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2021.100398_bib21","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1128\/JCM.02430-07","article-title":"Comparison of nine commercially available assays for quantification of antibody response to hepatitis B virus surface antigen","volume":"46","author":"Huzly","year":"2008","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jhepr.2021.100398_bib22","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1053\/j.gastro.2014.04.030","article-title":"Strategies to inhibit entry of HBV and HDV into hepatocytes","volume":"147","author":"Urban","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2021.100398_bib23","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"Elife"},{"key":"10.1016\/j.jhepr.2021.100398_bib24","doi-asserted-by":"crossref","first-page":"8882","DOI":"10.1128\/JVI.77.16.8882-8892.2003","article-title":"Endocytosis of hepatitis B immune globulin into hepatocytes inhibits the secretion of hepatitis B virus surface antigen and virions","volume":"77","author":"Schilling","year":"2003","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jhepr.2021.100398_bib25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/hep.22609","article-title":"Llama-derived single-domain intrabodies inhibit secretion of hepatitis B virions in mice","volume":"49","author":"Serruys","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2021.100398_bib26","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1086\/606119","article-title":"Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose","volume":"200","author":"McMahon","year":"2009","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jhepr.2021.100398_bib27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00430-014-0374-x","article-title":"Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1\/Pre-S2\/S vaccine","volume":"204","author":"Shouval","year":"2015","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.jhepr.2021.100398_bib28","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1053\/j.gastro.2013.07.044","article-title":"The hepatitis B vaccine protects re-exposed health care workers, but does not provide sterilizing immunity","volume":"145","author":"Werner","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2021.100398_bib29","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/hep.22796","article-title":"Efficacy of hepatitis B vaccine against antiviral drug-resistant hepatitis B virus mutants in the chimpanzee model","volume":"49","author":"Kamili","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2021.100398_bib30","doi-asserted-by":"crossref","first-page":"6532","DOI":"10.1128\/JVI.00234-14","article-title":"Commonly found variations\/mutations in the HBsAg of hepatitis B virus in the context of effective immunization programs: questionable clinical and public health significance","volume":"88","author":"Locarnini","year":"2014","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jhepr.2021.100398_bib31","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1172\/JCI116497","article-title":"The serology of chronic hepatitis B infection revisited","volume":"91","author":"Maruyama","year":"1993","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.jhepr.2021.100398_bib32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jhep.2021.07.031","article-title":"Role of anti-HBs in functional cure of HBeAg+ chronic hepatitis B patients infected with HBV genotype A","volume":"76","author":"Xu","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100398_bib33","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0016-5085(87)90427-6","article-title":"Frequency and significance of concurrent hepatitis B surface antigen and antibody in acute and chronic hepatitis B","volume":"93","author":"Shiels","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2021.100398_bib34","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/jvh.13312","article-title":"Prevalence and clinical features of patients with concurrent HBsAg and anti-HBs: evaluation of the hepatitis B research network cohort","volume":"27","author":"Lee","year":"2020","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.jhepr.2021.100398_bib35","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1034\/j.1600-0676.2001.021003207.x","article-title":"Efficacy and safety of an intravenous monoclonal anti-HBs in chronic hepatitis B patients","volume":"21","author":"van Nunen","year":"2001","journal-title":"Liver"},{"key":"10.1016\/j.jhepr.2021.100398_bib36","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1056\/NEJM199312163292503","article-title":"Liver transplantation in European patients with the hepatitis B surface antigen","volume":"329","author":"Samuel","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhepr.2021.100398_bib37","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0140-6736(81)90832-1","article-title":"Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Initial report of a randomised double-blind placebo-controlled trial","volume":"2","author":"Beasley","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.jhepr.2021.100398_bib38","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/hep.21482","article-title":"Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein","volume":"45","author":"Visvanathan","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2021.100398_bib39","doi-asserted-by":"crossref","first-page":"14913","DOI":"10.1073\/pnas.0406282101","article-title":"A\u00a0function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen","volume":"101","author":"Chen","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhepr.2021.100398_bib40","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1053\/j.gastro.2015.11.050","article-title":"Hepatitis B virus--specific and global T-cell dysfunction in chronic hepatitis B","volume":"150","author":"Park","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2021.100398_bib41","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1136\/gutjnl-2012-302408","article-title":"Cumulative viral evolutionary changes in chronic hepatitis B virus infection precedes hepatitis B e antigen seroconversion","volume":"62","author":"Cheng","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2021.100398_bib42","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0168-8278(87)80004-1","article-title":"Cytotoxic T-cell responses to the nucleocapsid proteins of HBV in chronic hepatitis. Evidence that antibody modulation may cause protracted infection","volume":"4","author":"Pignatelli","year":"1987","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100398_bib43","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jhep.2020.11.003","article-title":"Transition to HBeAg-negative chronic hepatitis B virus infection is associated with reduced cccDNA transcriptional activity","volume":"74","author":"Suslov","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100398_bib44","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.jhep.2017.07.011","article-title":"How viral genetic variants and genotypes influence disease and treatment outcome of chronic hepatitis B. Time for an individualised approach?","volume":"67","author":"Rajoriya","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100398_bib45","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.virol.2015.02.031","article-title":"Molecular biology of hepatitis B virus infection","volume":"479-480","author":"Seeger","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.jhepr.2021.100398_bib46","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1126\/science.3491425","article-title":"The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen","volume":"234","author":"Milich","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.jhepr.2021.100398_bib47","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/0016-5085(94)90761-7","article-title":"Distinguishing between acute and symptomatic chronic hepatitis B virus infection","volume":"106","author":"Maruyama","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2021.100398_bib48","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/gutjnl-2014-308546","article-title":"Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues","volume":"65","author":"Fan","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2021.100398_bib49","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.cgh.2018.05.047","article-title":"Serum level of antibodies against hepatitis B core protein is associated with clinical relapse after discontinuation of nucleos(t)ide analogue therapy","volume":"17","author":"Chi","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2021.100398_bib50","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00798-18","article-title":"Extracellular hepatitis B virus RNAs are heterogeneous in length and circulate as capsid-antibody complexes in addition to virions in chronic hepatitis B patients","volume":"92","author":"Bai","year":"2018","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jhepr.2021.100398_bib51","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev-immunol-041015-055531","article-title":"Memory B cells of mice and humans","volume":"35","author":"Weisel","year":"2017","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jhepr.2021.100398_bib52","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0021-9258(18)64385-6","article-title":"The secretion of antibody by isolated lymph node cells","volume":"236","author":"Helmreich","year":"1961","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jhepr.2021.100398_bib53","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.immuni.2020.11.006","article-title":"Germinal center and extrafollicular B cell responses in vaccination, immunity, and autoimmunity","volume":"53","author":"Elsner","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.jhepr.2021.100398_bib54","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cell.2020.08.025","article-title":"Loss of Bcl-6-expressing T follicular helper cells and germinal centers in COVID-19","volume":"183","author":"Kaneko","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jhepr.2021.100398_bib55","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0016-5085(93)90432-C","article-title":"Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group","volume":"104","author":"Lefkowitch","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2021.100398_bib56","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.immuni.2019.10.004","article-title":"Liver is a generative site for the B cell response to Ehrlichia muris","volume":"51","author":"Trivedi","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.jhepr.2021.100398_bib57","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.3389\/fimmu.2019.02458","article-title":"Challenges and opportunities for consistent classification of human B cell and plasma cell populations","volume":"10","author":"Sanz","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhepr.2021.100398_bib58","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.immuni.2018.08.012","article-title":"B\u00a0cells are the dominant antigen-presenting cells that activate naive CD4(+) T cells upon immunization with a virus-derived nanoparticle antigen","volume":"49","author":"Hong","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.jhepr.2021.100398_bib59","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1074-7613(02)00397-7","article-title":"Distinct role of surface lymphotoxin expressed by B cells in the organization of secondary lymphoid tissues","volume":"17","author":"Tumanov","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.jhepr.2021.100398_bib60","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.it.2007.10.004","article-title":"The 'short' history of regulatory B cells","volume":"29","author":"Mauri","year":"2008","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jhepr.2021.100398_bib61","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","article-title":"CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients","volume":"32","author":"Blair","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.jhepr.2021.100398_bib62","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.autrev.2011.11.026","article-title":"New insights into the pathogenesis of Beh\u00e7et's disease","volume":"11","author":"Pineton de Chambrun","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jhepr.2021.100398_bib63","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.4049\/jimmunol.178.10.6092","article-title":"Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis","volume":"178","author":"Duddy","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jhepr.2021.100398_bib64","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1189\/jlb.0812394","article-title":"DHA-enriched fish oil targets B cell lipid microdomains and enhances ex\u00a0vivo and in\u00a0vivo B cell function","volume":"93","author":"Gurzell","year":"2013","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.jhepr.2021.100398_bib65","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2893.2005.00651.x","article-title":"Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies","volume":"13","author":"Micallef","year":"2006","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.jhepr.2021.100398_bib66","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jhep.2010.10.016","article-title":"Enhanced B-cell differentiation and reduced proliferative capacity in chronic hepatitis C and chronic hepatitis B virus infections","volume":"55","author":"Oliviero","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100398_bib67","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/cmi.2015.25","article-title":"Reversal of B-cell hyperactivation and functional impairment is associated with HBsAg seroconversion in chronic hepatitis B patients","volume":"12","author":"Xu","year":"2015","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jhepr.2021.100398_bib68","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cellimm.2017.07.003","article-title":"Atypical memory B cells in human chronic infectious diseases: an interim report","volume":"321","author":"Portugal","year":"2017","journal-title":"Cell Immunol"},{"key":"10.1016\/j.jhepr.2021.100398_bib69","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1084\/jem.20072683","article-title":"Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals","volume":"205","author":"Moir","year":"2008","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jhepr.2021.100398_bib70","doi-asserted-by":"crossref","first-page":"15296","DOI":"10.1038\/s41598-018-33719-x","article-title":"HBV induces inhibitory FcRL receptor on B cells and dysregulates B cell-T follicular helper cell axis","volume":"8","author":"Poonia","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2021.100398_bib71","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1365-2036.2004.01906.x","article-title":"Review article: hepatitis vaccination in patients with chronic liver disease","volume":"19","author":"Reiss","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2021.100398_bib72","doi-asserted-by":"crossref","DOI":"10.1002\/hep.31890","article-title":"Current and past infections of hepatitis B virus do not increase mortality in patients with COVID-19","author":"Yip","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2021.100398_bib73","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s41591-021-01355-0","article-title":"Delayed production of neutralizing antibodies correlates with fatal COVID-19","volume":"27","author":"Lucas","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.jhepr.2021.100398_bib74","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/hep.27805","article-title":"Re-evaluation of hepatitis B virus clinical phases by systems biology identifies unappreciated roles for the innate immune response and B cells","volume":"62","author":"Vanwolleghem","year":"2015","journal-title":"Hepatology (Baltimore, Md)"},{"key":"10.1016\/j.jhepr.2021.100398_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179920","article-title":"Unique intrahepatic transcriptomics profiles discriminate the clinical phases of a chronic HBV infection","volume":"12","author":"Hou","year":"2017","journal-title":"PloS one"},{"key":"10.1016\/j.jhepr.2021.100398_bib76","doi-asserted-by":"crossref","first-page":"104283","DOI":"10.1016\/j.cellimm.2021.104283","article-title":"Sorted B cell transcriptomes point towards actively regulated B cell responses during ongoing chronic hepatitis B infections","volume":"362","author":"Van Hees","year":"2021","journal-title":"Cell Immunol"},{"key":"10.1016\/j.jhepr.2021.100398_bib77","doi-asserted-by":"crossref","first-page":"e1694","DOI":"10.1038\/cddis.2015.42","article-title":"T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance","volume":"6","author":"Ye","year":"2015","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jhepr.2021.100398_bib78","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41426-018-0034-0","article-title":"Use of ELISpot assay to study HBs-specific B cell responses in vaccinated and HBV infected humans","volume":"7","author":"Tian","year":"2018","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.jhepr.2021.100398_bib79","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1600-0676.1994.tb00071.x","article-title":"Fluctuations in viremia, aminotransferases and IgM antibody to hepatitis B core antigen in chronic hepatitis B patients with disease exacerbations","volume":"14","author":"Mels","year":"1994","journal-title":"Liver"},{"key":"10.1016\/j.jhepr.2021.100398_bib80","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cmi.2014.10.002","article-title":"Quantitative hepatitis B core antibody levels in the natural history of hepatitis B virus infection","volume":"21","author":"Song","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhepr.2021.100398_bib81","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.1097\/MD.0000000000000322","article-title":"Antibody to hepatitis B core antigen levels in the natural history of chronic hepatitis B: a prospective observational study","volume":"93","author":"Jia","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jhepr.2021.100398_bib82","doi-asserted-by":"crossref","first-page":"9792","DOI":"10.1128\/JVI.74.20.9792-9796.2000","article-title":"Intracellular hepatitis B virus nucleocapsids survive cytotoxic T-lymphocyte-induced apoptosis","volume":"74","author":"Pasquetto","year":"2000","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jhepr.2021.100398_bib83","doi-asserted-by":"crossref","first-page":"E11369","DOI":"10.1073\/pnas.1809028115","article-title":"Role of humoral immunity against hepatitis B virus core antigen in the pathogenesis of acute liver failure","volume":"115","author":"Chen","year":"2018","journal-title":"Proc Natl Acad Sci United States America"},{"key":"10.1016\/j.jhepr.2021.100398_bib84","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/jvh.13290","article-title":"Next-generation sequencing of the intrahepatic antibody repertoire delineates a unique B-cell response in HBV-associated acute liver failure","volume":"27","author":"Chen","year":"2020","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.jhepr.2021.100398_bib85","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008793","article-title":"Distinct disease features in chimpanzees infected with a precore HBV mutant associated with acute liver failure in humans","volume":"16","author":"Chen","year":"2020","journal-title":"Plos Pathog"},{"key":"10.1016\/j.jhepr.2021.100398_bib86","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S2468-1253(19)30344-9","article-title":"Serum alanine aminotransferase flares in chronic hepatitis B infection:\u00a0the good and the bad","volume":"5","author":"Ghany","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2021.100398_bib87","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/0016-5085(82)90007-5","article-title":"Core antigen-specific immunoglobulin G bound to the liver cell membrane in chronic hepatitis B","volume":"82","author":"Trevisan","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2021.100398_bib88","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jmb.2008.04.009","article-title":"Non-canonical binding of an antibody resembling a na\u00efve B cell receptor immunoglobulin to hepatitis B virus capsids","volume":"379","author":"Watts","year":"2008","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.jhepr.2021.100398_bib89","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1128\/JVI.75.14.6367-6374.2001","article-title":"Molecular basis for the interaction of the hepatitis B virus core antigen with the surface immunoglobulin receptor on naive B cells","volume":"75","author":"Lazdina","year":"2001","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jhepr.2021.100398_bib90","doi-asserted-by":"crossref","first-page":"14648","DOI":"10.1073\/pnas.94.26.14648","article-title":"Role of B cells in antigen presentation of the hepatitis B core","volume":"94","author":"Milich","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhepr.2021.100398_bib91","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1099\/vir.0.18678-0","article-title":"Priming of cytotoxic T cell responses to exogenous hepatitis B virus core antigen is B cell dependent","volume":"84","author":"Lazdina","year":"2003","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.jhepr.2021.100398_bib92","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/gutjnl-2018-316641","article-title":"Phenotypic and functional differences of HBV core-specific versus HBV polymerase-specific CD8+ T cells in chronically HBV-infected patients with low viral load","volume":"68","author":"Schuch","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2021.100398_bib93","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/gutjnl-2018-316644","article-title":"Phenotype and function of HBV-specific T cells is determined by the targeted epitope in addition to the stage of infection","volume":"68","author":"Hoogeveen","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2021.100398_bib94","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aau6905","article-title":"Multifactorial heterogeneity of virus-specific T cells and association with the progression of human chronic hepatitis B infection","volume":"4","author":"Cheng","year":"2019","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jhepr.2021.100398_bib95","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1172\/JCI83339","article-title":"In situ analysis of intrahepatic virological events in chronic hepatitis B virus infection","volume":"126","author":"Zhang","year":"2016","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhepr.2021.100398_bib96","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41586-019-1620-6","article-title":"Dynamics and genomic landscape of CD8(+) T cells undergoing hepatic priming","volume":"574","author":"B\u00e9n\u00e9chet","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jhepr.2021.100398_bib97","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1053\/j.gastro.2017.02.009","article-title":"Hepatitis B reactivation associated with immune suppressive and biological modifier therapies: current concepts, management strategies, and future directions","volume":"152","author":"Loomba","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2021.100398_bib98","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1084\/jem.20040119","article-title":"The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy","volume":"199","author":"Uchida","year":"2004","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jhepr.2021.100398_bib99","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1182\/blood.V100.6.2257","article-title":"Rituximab treatment results in impaired secondary humoral immune responsiveness","volume":"100","author":"van der Kolk","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jhepr.2021.100398_bib100","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1074-7613(00)80541-5","article-title":"Humoral immunity due to long-lived plasma cells","volume":"8","author":"Slifka","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.jhepr.2021.100398_bib101","doi-asserted-by":"crossref","first-page":"361","DOI":"10.4049\/jimmunol.180.1.361","article-title":"Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice","volume":"180","author":"DiLillo","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jhepr.2021.100398_bib102","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s00277-012-1405-6","article-title":"Analysis of hepatitis B surface antibody titers in B cell lymphoma patients after rituximab therapy","volume":"91","author":"Pei","year":"2012","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jhepr.2021.100398_bib103","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/hep.29082","article-title":"Role of surface antibody in hepatitis B reactivation in patients with resolved infection and hematologic malignancy: a meta-analysis","volume":"66","author":"Paul","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2021.100398_bib104","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jhep.2018.02.033","article-title":"Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection","volume":"69","author":"Yang","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100398_bib105","doi-asserted-by":"crossref","first-page":"20878","DOI":"10.1073\/pnas.0709205105","article-title":"Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice","volume":"104","author":"Bouaziz","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhepr.2021.100398_bib106","first-page":"3420","article-title":"Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression","volume":"118","author":"Matsushita","year":"2008","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhepr.2021.100398_bib107","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1053\/j.gastro.2020.02.058","article-title":"Safety and efficacy of 48 Weeks REP 2139 or REP 2165, tenofovir disoproxil, and pegylated interferon Alfa-2a in patients with chronic HBV infection na\u00efve to nucleos(t)ide therapy","volume":"158","author":"Bazinet","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2021.100398_bib108","article-title":"Long-term serological, virological and histological responses to RNA inhibition by ARC-520 in Chinese chronic hepatitis B patients on entecavir treatment","author":"Yuen","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2021.100398_bib109","article-title":"Safety, tolerability and pharmacokinetics ( pk) of single and multiple doses of alg-010133, an s-antigen transport inhibiting oligonucleotide polymer (stops) for the treatment of chronic hepatitis B","volume":"75","author":"Gane","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100398_bib110","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.chom.2020.05.010","article-title":"A\u00a0combination of human broadly neutralizing antibodies against hepatitis B virus HBsAg with distinct epitopes suppresses escape mutations","volume":"28","author":"Wang","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jhepr.2021.100398_bib111","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1172\/JCI45685","article-title":"Attenuation of HIV-associated human B cell exhaustion by siRNA downregulation of inhibitory receptors","volume":"121","author":"Kardava","year":"2011","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhepr.2021.100398_bib112","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nature07662","article-title":"Enhancing SIV-specific immunity in\u00a0vivo by PD-1 blockade","volume":"458","author":"Velu","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jhepr.2021.100398_bib113","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003856","article-title":"Enhancing virus-specific immunity in\u00a0vivo by combining therapeutic vaccination and PD-L1 blockade in chronic hepadnaviral infection","volume":"10","author":"Liu","year":"2014","journal-title":"Plos Pathog"},{"key":"10.1016\/j.jhepr.2021.100398_bib114","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.jhep.2019.06.028","article-title":"Anti-PD-1 blockade with nivolumab with and without therapeutic vaccination for virally suppressed chronic hepatitis B: a pilot study","volume":"71","author":"Gane","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100398_bib115","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1126\/science.1076071","article-title":"Maintenance of serological memory by polyclonal activation of human memory B cells","volume":"298","author":"Bernasconi","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jhepr.2021.100398_bib116","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.immuni.2008.03.019","article-title":"The B cell receptor governs the subcellular location of Toll-like receptor 9 leading to hyperresponses to DNA-containing antigens","volume":"28","author":"Chaturvedi","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.jhepr.2021.100398_bib117","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1053\/j.gastro.2018.01.030","article-title":"TLR7 agonist increases responses of hepatitis B virus-specific T cells and natural killer cells in patients with chronic hepatitis B treated with nucleos(T)ide analogues","volume":"154","author":"Boni","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2021.100398_bib118","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.jhep.2017.12.008","article-title":"Anti-HBV response to toll-like receptor 7 agonist GS-9620 is associated with\u00a0intrahepatic aggregates of T cells and B cells","volume":"68","author":"Li","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100398_bib119","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/ni.2573","article-title":"Intrahepatic myeloid-cell aggregates enable local proliferation of CD8(+) T cells and successful immunotherapy against chronic viral liver infection","volume":"14","author":"Huang","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhepr.2021.100398_bib120","doi-asserted-by":"crossref","first-page":"10808","DOI":"10.1038\/s41598-019-47149-w","article-title":"Synergy of therapeutic heterologous prime-boost hepatitis B vaccination with CpG-application to improve immune control of persistent HBV infection","volume":"9","author":"Kosinska","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2021.100398_bib121","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1182\/blood-2002-11-3569","article-title":"A\u00a0role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells","volume":"101","author":"Bernasconi","year":"2003","journal-title":"Blood"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555921001749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555921001749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:27:17Z","timestamp":1762900037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555921001749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":121,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S2589555921001749"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2021.100398","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Humoral immunity in hepatitis B virus infection: Rehabilitating the B in HBV","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2021.100398","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100398"}}